Skip to Content
  • Revenues ($M)$7,477
  • Revenue Percent Change1.3%
  • Profits ($M)$-239
  • Profits Percent Change-
  • Assets ($M)$18,133
  • Employees25,000
  • Market Value — as of March 31, 2016 ($M)$25,473
  • Previous Rank378
  • Morning Consult Brand Index
    C+

Boston Scientific makes medical devices that treat and diagnose medical conditions including heart disease and chronic pain.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Michael F. Mahoney
Sector
Health Care
Industry
Medical Products and Equipment
HQ Location
Marlborough, MA
Websitehttp://www.bostonscientific.com
Years on Fortune 500 List13
Employees25,000

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$7,4771.3%
Profits ($M)$-239-
Assets ($M)$18,133-
Total Stockholder Equity ($M)$6,320-
Market Value — as of March 31, 2016 ($M)$25,473-

Profit Ratios

Profit as % of Revenues-3.2%
Profits as % of Assets-1.3%
Profits as % of Stockholder Equity-3.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)-0.18
EPS % Change (from 2014)-
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)39.2%
Total Return to Investors (5 year, annualized)19.5%
Total Return to Investors (10 year, annualized)-2.8%